Details for New Drug Application (NDA): 214970
✉ Email this page to a colleague
The generic ingredient in ATROPINE SULFATE is atropine sulfate. There are twenty-three drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
Summary for 214970
Tradename: | ATROPINE SULFATE |
Applicant: | Medefil Inc |
Ingredient: | atropine sulfate |
Patents: | 0 |
Pharmacology for NDA: 214970
Mechanism of Action | Cholinergic Antagonists Cholinergic Muscarinic Antagonists |
Suppliers and Packaging for NDA: 214970
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 214970 | ANDA | Medefil, Inc. | 64253-400 | 64253-400-91 | 10 SYRINGE, PLASTIC in 1 BOX (64253-400-91) / 10 mL in 1 SYRINGE, PLASTIC (64253-400-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 1MG/10ML (0.1MG/ML) | ||||
Approval Date: | Nov 4, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription